181 related articles for article (PubMed ID: 21944698)
1. Estrogen-dependent activation of neutral cholesterol ester hydrolase underlying gender difference of atherogenesis in apoE-/- mice.
Chiba T; Ikeda M; Umegaki K; Tomita T
Atherosclerosis; 2011 Dec; 219(2):545-51. PubMed ID: 21944698
[TBL] [Abstract][Full Text] [Related]
2. Pivotal role of serum- and glucocorticoid-inducible kinase 1 in vascular inflammation and atherogenesis.
Borst O; Schaub M; Walker B; Schmid E; Münzer P; Voelkl J; Alesutan I; Rodríguez JM; Vogel S; Schoenberger T; Metzger K; Rath D; Umbach A; Kuhl D; Müller II; Seizer P; Geisler T; Gawaz M; Lang F
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):547-57. PubMed ID: 25614279
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effects of tanshinone IIA on atherosclerostic vessels of ovariectomized ApoE mice are mediated by estrogen receptor activation and through the ERK signaling pathway.
Liu X; Guo CY; Ma XJ; Wu CF; Zhang Y; Sun MY; Pan YT; Yin HJ
Cell Physiol Biochem; 2015; 35(5):1744-55. PubMed ID: 25832326
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
Sontag TJ; Krishack PA; Lukens JR; Bhanvadia CV; Getz GS; Reardon CA
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):262-9. PubMed ID: 24334873
[TBL] [Abstract][Full Text] [Related]
5. Expression of type IIA secretory phospholipase A2 inhibits cholesteryl ester transfer protein activity in transgenic mice.
Hurt-Camejo E; Gautier T; Rosengren B; Dikkers A; Behrendt M; Grass DS; Rader DJ; Tietge UJ
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2707-14. PubMed ID: 24115030
[TBL] [Abstract][Full Text] [Related]
6. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
[TBL] [Abstract][Full Text] [Related]
7. Effects of oral estrogen on aortic ROS-generating and -scavenging enzymes and atherosclerosis in apoE-deficient mice.
Wing LY; Chen YC; Shih YY; Cheng JC; Lin YJ; Jiang MJ
Exp Biol Med (Maywood); 2009 Sep; 234(9):1037-46. PubMed ID: 19546345
[TBL] [Abstract][Full Text] [Related]
8. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M
Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738
[TBL] [Abstract][Full Text] [Related]
9. 17beta-estradiol prevents early-stage atherosclerosis in estrogen receptor-alpha deficient female mice.
Villablanca AC; Tenwolde A; Lee M; Huck M; Mumenthaler S; Rutledge JC
J Cardiovasc Transl Res; 2009 Sep; 2(3):289-99. PubMed ID: 19654889
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of early atherogenesis in low-density lipoprotein receptor-deficient mice by proteasome inhibition.
Wilck N; Fechner M; Dreger H; Hewing B; Arias A; Meiners S; Baumann G; Stangl V; Stangl K; Ludwig A
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1418-26. PubMed ID: 22516063
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 receptor type-1 in non-hematopoietic cells is the target for the pro-atherogenic effects of interleukin-1 in apoE-deficient mice.
Shemesh S; Kamari Y; Shaish A; Olteanu S; Kandel-Kfir M; Almog T; Grosskopf I; Apte RN; Harats D
Atherosclerosis; 2012 Jun; 222(2):329-36. PubMed ID: 22236482
[TBL] [Abstract][Full Text] [Related]
12. 17β-estradiol induces vasorelaxation by stimulating endothelial hydrogen sulfide release.
Zhou K; Gao Q; Zheng S; Pan S; Li P; Suo K; Simoncini T; Wang T; Fu X
Mol Hum Reprod; 2013 Mar; 19(3):169-76. PubMed ID: 23041593
[TBL] [Abstract][Full Text] [Related]
13. EphA2 knockdown attenuates atherosclerotic lesion development in ApoE(-/-) mice.
Jiang H; Li X; Zhang X; Liu Y; Huang S; Wang X
Cardiovasc Pathol; 2014; 23(3):169-74. PubMed ID: 24561077
[TBL] [Abstract][Full Text] [Related]
14. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
[TBL] [Abstract][Full Text] [Related]
15. nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe
Lallemand T; Rouahi M; Swiader A; Grazide MH; Geoffre N; Alayrac P; Recazens E; Coste A; Salvayre R; Nègre-Salvayre A; Augé N
Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1479-1492. PubMed ID: 29794115
[TBL] [Abstract][Full Text] [Related]
16. Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation.
Ma KL; Liu J; Wang CX; Ni J; Zhang Y; Wu Y; Lv LL; Ruan XZ; Liu BC
Cardiovasc Res; 2013 Dec; 100(3):450-60. PubMed ID: 24068000
[TBL] [Abstract][Full Text] [Related]
17. Increased plasma S-adenosylhomocysteine-accelerated atherosclerosis is associated with epigenetic regulation of endoplasmic reticulum stress in apoE-/- mice.
Xiao Y; Huang W; Zhang J; Peng C; Xia M; Ling W
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):60-70. PubMed ID: 25359864
[TBL] [Abstract][Full Text] [Related]
18. Glyoxalase 1 overexpression does not affect atherosclerotic lesion size and severity in ApoE-/- mice with or without diabetes.
Hanssen NM; Brouwers O; Gijbels MJ; Wouters K; Wijnands E; Cleutjens JP; De Mey JG; Miyata T; Biessen EA; Stehouwer CD; Schalkwijk CG
Cardiovasc Res; 2014 Oct; 104(1):160-70. PubMed ID: 25139743
[TBL] [Abstract][Full Text] [Related]
19. Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
Chiwata T; Aragane K; Fujinami K; Kojima K; Ishibashi S; Yamada N; Kusunoki J
Br J Pharmacol; 2001 Aug; 133(7):1005-12. PubMed ID: 11487509
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial aldehyde dehydrogenase activation by Alda-1 inhibits atherosclerosis and attenuates hepatic steatosis in apolipoprotein E-knockout mice.
Stachowicz A; Olszanecki R; Suski M; Wiśniewska A; Totoń-Żurańska J; Madej J; Jawień J; Białas M; Okoń K; Gajda M; Głombik K; Basta-Kaim A; Korbut R
J Am Heart Assoc; 2014 Nov; 3(6):e001329. PubMed ID: 25392542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
